Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Conditional tenomodulin overexpression favors tenogenic lineage differentiation of transgenic mouse derived cells.

Shi Y., Xiong Y., Jiang Y., Zhang Z., Zhou G., Zhang W.

Animal Study on Tendon Injury, published in Gene (2016) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Gene (2016)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
27777108
DOI
10.1016/j.gene.2016.10.028
Citations
12

Abstract (original English)

Tenomodulin (TNMD) is a type II transmembrane protein that is widely expressed in a variety of avascular connective tissues and fat tissue. Its function remains largely unknown except for a marker for mature tenocytes. This study reports the generation of tetracycline (Tet)-on driven conditional TNMD overexpressing mice and thus to provide a tool for systemic investigation of its role in regulating functions of various tissues. The current study focuses on in vitro comparison of tenogenic differentiation potentials induced by doxycycline (Dox) treatment among bone marrow derived stem cells (BMSCs), adipose derived stem cells (ASCs), dermal fibroblasts (DFs) and tenocytes (TCs) of the same transgenic mice. The results showed that BMSCs exhibited the best tenogenic potential than other three cell types (p<0.05 for majority of markers), whereas ASCs and DFs revealed similar potentials (p>0.05 for majority of markers). TCs were found the least capable of being induced for tenogenic gene expression. In addition, TNMD overexpression also significantly inhibited the differentiation towards osteogenic and chondrogenic lineages in both BMSCs and ASCs (p<0.05). However, the inhibition of adipogenic differentiation was not observed in ASCs (p>0.05), suggesting different gene regulation mechanisms may involve in different tissue types and thus leading to different functions, which is likel

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adult Stem CellsAnimalsCell DifferentiationCell LineageCell ProliferationCell TransdifferentiationCells, CulturedColony-Forming Units AssayFibroblastsMembrane Proteins

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research